ArticleBMC cancer2011

Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study.

Dusan Kotasek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.